1. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C
- Author
-
Kahoud, R., Doerfler, M., Janas, A., Hong, S.J., Potera, R.M., Topjian, A., Yacoub, M., Rodriguez, I.S., Yun, J., Pryce, P., Czech, T., Guilliams, K.P., Walson, K.H., Geneslaw, A.S., Drury, K., Nagpal, A., Lin, J.E., Dapul, H., Farias-Moeller, R., Robertson, C.L., Campos-Miño, S., Bhagat, D., Roa, J.D., Francoeur, C., Stulce, C., Snooks, K.C., Alcamo, A.M., Chang, C.-C.H., Ferrazzano, P., Domínguez Rojas, J.A., Muller, W.J., Muñoz, J.T., Wellnitz, K., Williams, C.N., Zivick, E., Vargas, W.S., Holloway, A., Santos, L., Fink, E.L., Appavu, B., Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) Investigators, Schober, M.E., Rasmussen, L., Wainwright, M.S., Even, K.M., Agner, S.C., Sewell, T.B., Lovett, M.E., Silver, W.G., Price, D., Brunow de Carvalho, W., Schwartz, S.P., Nelson, A., Dervan, L.A., Walker, T.C., and McGuire, J.L.
- Abstract
Background: Our objective was to characterize the frequency, early impact, and risk factors for neurological manifestations in hospitalized children with acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or multisystem inflammatory syndrome in children (MIS-C). Methods: Multicenter, cross-sectional study of neurological manifestations in children aged
- Published
- 2022
- Full Text
- View/download PDF